Cirrhosis is a progressive liver disease. In severe cases, cirrhosis can progress to decompensated cirrhosis. At this point, the liver loses function, and that may lead to serious symptoms and ...

Cirrhosis, a chronic liver disease, progressively replaces healthy cells with scar tissue, impairing detoxification and ...

In contrast, decompensated cirrhosis refers to when the liver can no longer function adequately. As such, a person living with compensated cirrhosis may not notice any symptoms.

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious complications like ascites and hepatic encephalopathy.

Decompensated cirrhosis, according to doctors, describes the complications of an advanced liver disease. Those with this condition are nearing end-stage liver failure and may need a liver ...

Lamivudine is an orally administered nucleoside analogue. The active compound, lamivudine triphosphate, competes with deoxycytidine triphosphate (dCTP) for incorporation into growing DNA chains ...

Source Reference: Pose E, et al "Simvastatin and rifaximin in decompensated cirrhosis: a randomized clinical trial" JAMA 2025; DOI: 10.1001/jama.2024.27441. Share on Facebook.

Adding combination treatment with simvastatin and rifaximin to standard therapy did not prevent severe complications in patients with decompensated cirrhosis, a European randomized trial found ...

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American ...